Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Baxter Healthcare Corporation recalls Daptomycin

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations
Products
  • Daptomycin
Where it was sold

US Nationwide; Puerto Rico; and Chile.

Nationwide

Units affected
N/A
About this recall
Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0714-24.